Detalhe da pesquisa
1.
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.
Nat Cell Biol
; 24(4): 554-564, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411083
2.
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Cell Death Dis
; 13(8): 710, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973998